Clinical Trials Browser

Phase 2 × Hepatitis B, Chronic × Gastrointestinal × Clear all

NCT02289300 2020-01-13

A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients

Phase 2 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis, Hepatitis B, Chronic